Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 490.50
Ask: 495.50
Change: 0.00 (0.00%)
Spread: 5.00 (1.019%)
Open: 486.00
High: 493.00
Low: 484.50
Prev. Close: 490.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Treatt (TET): Sweet upgrades

19 May 2021 07:00

Edison Investment Research Limited Treatt (TET): Sweet upgrades 19-May-2021 / 07:00 GMT/BST


 

London, UK, 19 May 2021

 

Treatt (TET): Sweet upgrades

Treatt has once again demonstrated the strength of its business model, with another excellent set of results, and yet another upgrade to guidance. The performance continues to be testament to the management and culture of the business, which has been transformed under CEO Daemmon Reeve's nine years at the helm. Both sales and profit performance are impressive, and we once again raise our forecasts, as the 'healthier' categories continue to outperform. The relocation of the UK business is under way, and we expect the business to continue to perform well once the new UK capacity comes on stream.

 

Treatt trades at 40.7x and 28.1x FY21 P/E and EV/EBITDA, representing premiums of c 30% and c 40% respectively to its peers. We note that the current share price is discounting medium-term sales growth of 5.0%, falling to 2.5% in perpetuity, with a WACC of 5.7% and a terminal EBIT margin of 20.0%. We forecast net debt at end FY21, moving to a net cash position thereafter, and hence expect a significant uplift in the dividend in FY21.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Sara Welford +44 (0)20 3077 5700 consumer@edisongroup.com

Russell Pointon +44 (0)20 3077 5700 consumer@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1198024 19-May-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th Jan 20184:32 pmRNSResult of AGM
25th Jan 20181:47 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSVoting Rights and Captial
22nd Dec 20179:01 amRNSHolding(s) in Company
21st Dec 20173:23 pmRNSHolding(s) in Company
19th Dec 20173:46 pmRNSDirector/PDMR Shareholding
19th Dec 20173:20 pmRNSHolding(s) in Company
18th Dec 20173:41 pmRNSResult of General Meeting
14th Dec 201710:41 amRNSAnnual Financial Report
6th Dec 20175:04 pmRNSHolding(s) in Company
1st Dec 20174:16 pmRNSBlock Listing Six Monthly Return
1st Dec 20177:00 amRNSTotal Voting Rights
28th Nov 20177:00 amRNSPlacing to raise £21.6 million
28th Nov 20177:00 amRNSFinal Results
10th Nov 201712:34 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTrading Update
29th Sep 20175:14 pmRNSTotal Voting Rights
26th Sep 20178:54 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSHolding(s) in Company
21st Aug 201711:09 amRNSDirector/PDMR Shareholding
2nd Aug 20175:07 pmRNSTotal Voting Rights
20th Jul 20171:50 pmRNSDirector/PDMR Shareholding
5th Jun 20171:35 pmRNSBlock Listing Six Monthly Return
23rd May 20179:30 amRNSBlock Listing Application
11th May 20174:05 pmRNSHolding(s) in Company
11th May 20174:01 pmRNSDirector/PDMR Shareholding
10th May 20172:53 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHalf-year Report
5th Apr 20174:41 pmRNSHolding(s) in Company
3rd Apr 20175:25 pmRNSDirector/PDMR Shareholding
31st Mar 20173:57 pmRNSTotal Voting Rights
30th Mar 20177:00 amRNSTrading Statement
27th Mar 20179:30 amRNSHolding(s) in Company
24th Mar 20173:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20174:50 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSDirector/PDMR Shareholding
23rd Feb 20177:00 amRNSTrading Statement
20th Feb 20174:03 pmRNSDirector/PDMR Shareholding
14th Feb 20178:15 amRNSHolding(s) in Company
10th Feb 20179:41 amRNSHolding(s) in Company
1st Feb 20172:19 pmRNSDirector/PDMR Shareholding
30th Jan 20175:58 pmRNSNotification of a Transaction of a Director
27th Jan 20174:42 pmRNSResult of AGM
27th Jan 20177:15 amRNSTrading Statement
30th Dec 20167:00 amRNSTotal Voting Rights
30th Dec 20167:00 amRNSAnnual Information Update
22nd Dec 20163:11 pmRNSUpdate on Site Relocation
20th Dec 201610:26 amRNSDirector/PDMR Shareholding
13th Dec 20161:11 pmRNSNotification of Transactions of Directors
9th Dec 20163:05 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.